Lonza Group, CH0013841017

Lonza Group stock reports 16.00 percent H1 sales growth

Published on 09/29/2026 at 14:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Lonza Group stock carries a 34.80 percent H1 Core EBITDA margin after CHF 3.4 billion in sales. The 2026 margin outlook stands at 33.00-34.00 percent.

Fotorealistische Reinraum-Bioreaktor-Halle mit glänzenden Edelstahltanks und steriler LED-Beleuchtung
Lonza CH0013841017 zeigt Reinraum Bioreaktor Halle mit Edelstahl Tanks steriler LED Beleuchtung, Illustration mit AI erstellt.

Lonza Group stock (ISIN CH0013841017) was trading at EUR 617.50 at Lang & Schwarz on September 29, 2026, at 2:43 p.m. CEST, up 0.18 percent versus the prior close of EUR 616.40. The company entered the second half of 2026 with CHF 3.4 billion in first-half sales and a 34.80 percent Core EBITDA margin, according to Yahoo Finance on July 22, 2026.

Margin outlook moves higher

Lonza raised its full-year 2026 Core EBITDA margin outlook to 33.00-34.00 percent from above 32.00 percent and maintained its expectation for 11.00-12.00 percent constant-exchange-rate sales growth. The upgrade followed a 4.40 percentage-point year-over-year increase in the H1 margin, giving the guidance change a measurable earnings base.

Free cash flow reached CHF 426 million in H1 2026, compared with CHF 116 million in H1 2025, while capital expenditure totaled CHF 530 million. Those figures point to a stronger cash contribution alongside the reported margin expansion, although investment intensity remains material for a contract development and manufacturing organization.

Advanced Synthesis sets the pace

Advanced Synthesis generated CHF 834 million in H1 sales, up 27.70 percent at constant exchange rates from H1 2025, and posted a 48.10 percent Core EBITDA margin. Yahoo Finance reported that management expects second-half growth and margins in the platform to normalize against a stronger prior-year base.

That normalization is the key counterweight to the H1 comparison. Investing.com reported on September 16, 2026, that management described the 48.00 percent segment margin as a peak level, with a more normal level near 40.00 percent over time.

US capacity expands

Lonza is also extending its manufacturing footprint. In a release dated September 10, 2026, EQS News said the new commercial spray-drying facility in Bend, Oregon, is expected to be completed in 2029 and initially create more than 80 jobs. The project adds a concrete capacity milestone to Lonza's longer-term CDMO expansion.

Lonza stock stays near its yearly high

Lonza Group stock was trading at EUR 617.50 at Lang & Schwarz on September 29, 2026, at 2:43 p.m. CEST, plus 0.18 percent versus the prior close of EUR 616.40. On the SIX Swiss Exchange, the stock's 52-week high was CHF 597.80 on August 25, 2026, according to market data cited by finanzen.ch.

Lonza Group stock facts

  • Company: Lonza Group AG
  • ISIN: CH0013841017
  • Ticker: LONN
  • Primary exchange: SIX Swiss Exchange
  • Price Lang & Schwarz (as of September 29, 2026, 2:43 p.m. CEST): EUR 617.50
  • Change versus prior close: plus 0.18 percent
  • Prior close Lang & Schwarz (September 28, 2026): EUR 616.40
  • Market capitalization: CHF 40.8 billion (as of September 29, 2026)
  • Sector / Industry: Healthcare / Biotechnology

More news and analyses on Lonza Group stock

Disclaimer...

en | CH0013841017 | LONZA GROUP | boerse | 70198552 | bgmi